nodes	percent_of_prediction	percent_of_DWPC	metapath
Dactinomycin—uterine cancer—ovarian cancer	0.204	0.407	CtDrD
Dactinomycin—testicular cancer—ovarian cancer	0.152	0.303	CtDrD
Dactinomycin—germ cell cancer—ovarian cancer	0.146	0.29	CtDrD
Dactinomycin—ABCB1—ovarian cancer	0.124	1	CbGaD
Dactinomycin—ABCC6—Doxorubicin—ovarian cancer	0.0513	0.183	CbGbCtD
Dactinomycin—ABCG2—Topotecan—ovarian cancer	0.038	0.135	CbGbCtD
Dactinomycin—ABCC1—Epirubicin—ovarian cancer	0.0285	0.102	CbGbCtD
Dactinomycin—ABCC1—Paclitaxel—ovarian cancer	0.0281	0.1	CbGbCtD
Dactinomycin—ABCC1—Docetaxel—ovarian cancer	0.0203	0.0725	CbGbCtD
Dactinomycin—ABCG2—Paclitaxel—ovarian cancer	0.0188	0.0671	CbGbCtD
Dactinomycin—ABCG2—Carboplatin—ovarian cancer	0.0177	0.0631	CbGbCtD
Dactinomycin—ABCC1—Doxorubicin—ovarian cancer	0.0151	0.054	CbGbCtD
Dactinomycin—ABCB1—Topotecan—ovarian cancer	0.0137	0.0489	CbGbCtD
Dactinomycin—ABCG2—Docetaxel—ovarian cancer	0.0136	0.0485	CbGbCtD
Dactinomycin—ABCG2—Doxorubicin—ovarian cancer	0.0101	0.0361	CbGbCtD
Dactinomycin—ABCB1—Vinorelbine—ovarian cancer	0.00965	0.0344	CbGbCtD
Dactinomycin—ABCB1—Paclitaxel—ovarian cancer	0.00678	0.0242	CbGbCtD
Dactinomycin—ABCB1—Docetaxel—ovarian cancer	0.0049	0.0175	CbGbCtD
Dactinomycin—ABCB1—Doxorubicin—ovarian cancer	0.00365	0.013	CbGbCtD
Dactinomycin—ABCC1—myometrium—ovarian cancer	0.0004	0.0524	CbGeAlD
Dactinomycin—SLC22A5—myometrium—ovarian cancer	0.000352	0.0461	CbGeAlD
Dactinomycin—ABCG2—myometrium—ovarian cancer	0.000331	0.0434	CbGeAlD
Dactinomycin—ABCC1—uterine cervix—ovarian cancer	0.000311	0.0408	CbGeAlD
Dactinomycin—ABCC1—decidua—ovarian cancer	0.000296	0.0389	CbGeAlD
Dactinomycin—ABCC1—endometrium—ovarian cancer	0.000281	0.0369	CbGeAlD
Dactinomycin—SLC22A5—uterine cervix—ovarian cancer	0.000274	0.0359	CbGeAlD
Dactinomycin—ABCC1—uterus—ovarian cancer	0.000259	0.034	CbGeAlD
Dactinomycin—ABCG2—uterine cervix—ovarian cancer	0.000257	0.0338	CbGeAlD
Dactinomycin—SLC22A5—endometrium—ovarian cancer	0.000247	0.0325	CbGeAlD
Dactinomycin—ABCG2—decidua—ovarian cancer	0.000245	0.0322	CbGeAlD
Dactinomycin—ABCG2—endometrium—ovarian cancer	0.000233	0.0305	CbGeAlD
Dactinomycin—ABCG2—uterus—ovarian cancer	0.000215	0.0282	CbGeAlD
Dactinomycin—ABCC1—female gonad—ovarian cancer	0.000212	0.0278	CbGeAlD
Dactinomycin—ABCC1—vagina—ovarian cancer	0.000211	0.0276	CbGeAlD
Dactinomycin—SLC22A5—female reproductive system—ovarian cancer	0.000205	0.0269	CbGeAlD
Dactinomycin—ABCC1—testis—ovarian cancer	0.000188	0.0247	CbGeAlD
Dactinomycin—SLC22A5—female gonad—ovarian cancer	0.000186	0.0245	CbGeAlD
Dactinomycin—SLC22A5—vagina—ovarian cancer	0.000185	0.0243	CbGeAlD
Dactinomycin—ABCG2—bone marrow—ovarian cancer	0.000182	0.0239	CbGeAlD
Dactinomycin—ABCG2—female gonad—ovarian cancer	0.000176	0.023	CbGeAlD
Dactinomycin—ABCG2—vagina—ovarian cancer	0.000174	0.0229	CbGeAlD
Dactinomycin—SLC22A5—testis—ovarian cancer	0.000165	0.0217	CbGeAlD
Dactinomycin—ABCB1—myometrium—ovarian cancer	0.000163	0.0214	CbGeAlD
Dactinomycin—ABCB1—embryo—ovarian cancer	0.000157	0.0206	CbGeAlD
Dactinomycin—ABCG2—testis—ovarian cancer	0.000156	0.0204	CbGeAlD
Dactinomycin—Alopecia—Vinorelbine—ovarian cancer	0.000144	0.00167	CcSEcCtD
Dactinomycin—Extravasation—Epirubicin—ovarian cancer	0.000143	0.00166	CcSEcCtD
Dactinomycin—Aspartate aminotransferase increased—Paclitaxel—ovarian cancer	0.000143	0.00165	CcSEcCtD
Dactinomycin—Toxic epidermal necrolysis—Paclitaxel—ovarian cancer	0.000143	0.00165	CcSEcCtD
Dactinomycin—Erythema—Vinorelbine—ovarian cancer	0.000142	0.00164	CcSEcCtD
Dactinomycin—Myalgia—Topotecan—ovarian cancer	0.000141	0.00164	CcSEcCtD
Dactinomycin—Discomfort—Topotecan—ovarian cancer	0.00014	0.00162	CcSEcCtD
Dactinomycin—Myalgia—Melphalan—ovarian cancer	0.000138	0.0016	CcSEcCtD
Dactinomycin—Lethargy—Docetaxel—ovarian cancer	0.000137	0.00159	CcSEcCtD
Dactinomycin—Dysphagia—Paclitaxel—ovarian cancer	0.000137	0.00159	CcSEcCtD
Dactinomycin—Hypocalcaemia—Epirubicin—ovarian cancer	0.000137	0.00158	CcSEcCtD
Dactinomycin—ABCC1—lymph node—ovarian cancer	0.000136	0.0179	CbGeAlD
Dactinomycin—Infection—Topotecan—ovarian cancer	0.000135	0.00156	CcSEcCtD
Dactinomycin—Oedema—Melphalan—ovarian cancer	0.000133	0.00154	CcSEcCtD
Dactinomycin—Thrombocytopenia—Topotecan—ovarian cancer	0.000133	0.00154	CcSEcCtD
Dactinomycin—Extravasation—Doxorubicin—ovarian cancer	0.000133	0.00153	CcSEcCtD
Dactinomycin—Decreased appetite—Chlorambucil—ovarian cancer	0.000132	0.00153	CcSEcCtD
Dactinomycin—Ulcer—Epirubicin—ovarian cancer	0.000132	0.00153	CcSEcCtD
Dactinomycin—Infection—Melphalan—ovarian cancer	0.000132	0.00153	CcSEcCtD
Dactinomycin—Ill-defined disorder—Vinorelbine—ovarian cancer	0.000132	0.00152	CcSEcCtD
Dactinomycin—Anaemia—Vinorelbine—ovarian cancer	0.000131	0.00152	CcSEcCtD
Dactinomycin—Fatigue—Chlorambucil—ovarian cancer	0.000131	0.00152	CcSEcCtD
Dactinomycin—Pancytopenia—Paclitaxel—ovarian cancer	0.00013	0.00151	CcSEcCtD
Dactinomycin—Pain—Chlorambucil—ovarian cancer	0.00013	0.00151	CcSEcCtD
Dactinomycin—Thrombocytopenia—Melphalan—ovarian cancer	0.00013	0.0015	CcSEcCtD
Dactinomycin—Anorexia—Topotecan—ovarian cancer	0.000129	0.00149	CcSEcCtD
Dactinomycin—Neutropenia—Paclitaxel—ovarian cancer	0.000128	0.00148	CcSEcCtD
Dactinomycin—Malaise—Vinorelbine—ovarian cancer	0.000128	0.00148	CcSEcCtD
Dactinomycin—ABCB1—epithelium—ovarian cancer	0.000128	0.0168	CbGeAlD
Dactinomycin—Leukopenia—Vinorelbine—ovarian cancer	0.000127	0.00147	CcSEcCtD
Dactinomycin—ABCB1—uterine cervix—ovarian cancer	0.000127	0.0167	CbGeAlD
Dactinomycin—Anorexia—Melphalan—ovarian cancer	0.000127	0.00146	CcSEcCtD
Dactinomycin—Hypocalcaemia—Doxorubicin—ovarian cancer	0.000126	0.00146	CcSEcCtD
Dactinomycin—Feeling abnormal—Chlorambucil—ovarian cancer	0.000126	0.00145	CcSEcCtD
Dactinomycin—Gastrointestinal pain—Chlorambucil—ovarian cancer	0.000125	0.00144	CcSEcCtD
Dactinomycin—Liver function test abnormal—Docetaxel—ovarian cancer	0.000124	0.00144	CcSEcCtD
Dactinomycin—Musculoskeletal discomfort—Topotecan—ovarian cancer	0.000124	0.00143	CcSEcCtD
Dactinomycin—Pneumonia—Paclitaxel—ovarian cancer	0.000123	0.00142	CcSEcCtD
Dactinomycin—Ulcer—Doxorubicin—ovarian cancer	0.000122	0.00141	CcSEcCtD
Dactinomycin—Stevens-Johnson syndrome—Paclitaxel—ovarian cancer	0.000121	0.0014	CcSEcCtD
Dactinomycin—Aspartate aminotransferase increased—Docetaxel—ovarian cancer	0.000121	0.0014	CcSEcCtD
Dactinomycin—Toxic epidermal necrolysis—Docetaxel—ovarian cancer	0.000121	0.0014	CcSEcCtD
Dactinomycin—Myalgia—Vinorelbine—ovarian cancer	0.000121	0.0014	CcSEcCtD
Dactinomycin—ABCB1—decidua—ovarian cancer	0.000121	0.0159	CbGeAlD
Dactinomycin—Musculoskeletal discomfort—Melphalan—ovarian cancer	0.000121	0.0014	CcSEcCtD
Dactinomycin—Abdominal pain—Chlorambucil—ovarian cancer	0.00012	0.00139	CcSEcCtD
Dactinomycin—Body temperature increased—Chlorambucil—ovarian cancer	0.00012	0.00139	CcSEcCtD
Dactinomycin—SLC22A5—lymph node—ovarian cancer	0.00012	0.0157	CbGeAlD
Dactinomycin—Discomfort—Vinorelbine—ovarian cancer	0.00012	0.00138	CcSEcCtD
Dactinomycin—Stomatitis—Paclitaxel—ovarian cancer	0.000119	0.00138	CcSEcCtD
Dactinomycin—Decreased appetite—Topotecan—ovarian cancer	0.000118	0.00136	CcSEcCtD
Dactinomycin—Aplastic anaemia—Epirubicin—ovarian cancer	0.000117	0.00136	CcSEcCtD
Dactinomycin—Fatigue—Topotecan—ovarian cancer	0.000117	0.00135	CcSEcCtD
Dactinomycin—Dysphagia—Docetaxel—ovarian cancer	0.000116	0.00134	CcSEcCtD
Dactinomycin—Pain—Topotecan—ovarian cancer	0.000116	0.00134	CcSEcCtD
Dactinomycin—Decreased appetite—Melphalan—ovarian cancer	0.000115	0.00133	CcSEcCtD
Dactinomycin—Infection—Vinorelbine—ovarian cancer	0.000115	0.00133	CcSEcCtD
Dactinomycin—ABCB1—endometrium—ovarian cancer	0.000115	0.0151	CbGeAlD
Dactinomycin—Fatigue—Melphalan—ovarian cancer	0.000114	0.00132	CcSEcCtD
Dactinomycin—Oesophagitis—Epirubicin—ovarian cancer	0.000114	0.00132	CcSEcCtD
Dactinomycin—Thrombocytopenia—Vinorelbine—ovarian cancer	0.000114	0.00131	CcSEcCtD
Dactinomycin—Pain—Melphalan—ovarian cancer	0.000114	0.00131	CcSEcCtD
Dactinomycin—Mouth ulceration—Epirubicin—ovarian cancer	0.000113	0.00131	CcSEcCtD
Dactinomycin—ABCG2—lymph node—ovarian cancer	0.000113	0.0148	CbGeAlD
Dactinomycin—Hypersensitivity—Chlorambucil—ovarian cancer	0.000112	0.0013	CcSEcCtD
Dactinomycin—Feeling abnormal—Topotecan—ovarian cancer	0.000112	0.00129	CcSEcCtD
Dactinomycin—Gastrointestinal pain—Topotecan—ovarian cancer	0.000111	0.00128	CcSEcCtD
Dactinomycin—Anorexia—Vinorelbine—ovarian cancer	0.000111	0.00128	CcSEcCtD
Dactinomycin—Pancytopenia—Docetaxel—ovarian cancer	0.00011	0.00128	CcSEcCtD
Dactinomycin—Asthenia—Chlorambucil—ovarian cancer	0.000109	0.00126	CcSEcCtD
Dactinomycin—Pharyngitis—Paclitaxel—ovarian cancer	0.000109	0.00126	CcSEcCtD
Dactinomycin—Neutropenia—Docetaxel—ovarian cancer	0.000109	0.00126	CcSEcCtD
Dactinomycin—Aplastic anaemia—Doxorubicin—ovarian cancer	0.000109	0.00126	CcSEcCtD
Dactinomycin—Sepsis—Epirubicin—ovarian cancer	0.000108	0.00125	CcSEcCtD
Dactinomycin—Abdominal pain—Topotecan—ovarian cancer	0.000107	0.00124	CcSEcCtD
Dactinomycin—Body temperature increased—Topotecan—ovarian cancer	0.000107	0.00124	CcSEcCtD
Dactinomycin—ABCB1—gonad—ovarian cancer	0.000107	0.014	CbGeAlD
Dactinomycin—ABCB1—uterus—ovarian cancer	0.000106	0.0139	CbGeAlD
Dactinomycin—Oesophagitis—Doxorubicin—ovarian cancer	0.000106	0.00122	CcSEcCtD
Dactinomycin—Musculoskeletal discomfort—Vinorelbine—ovarian cancer	0.000106	0.00122	CcSEcCtD
Dactinomycin—Phlebitis—Epirubicin—ovarian cancer	0.000105	0.00122	CcSEcCtD
Dactinomycin—Mouth ulceration—Doxorubicin—ovarian cancer	0.000105	0.00121	CcSEcCtD
Dactinomycin—Pneumonia—Docetaxel—ovarian cancer	0.000104	0.00121	CcSEcCtD
Dactinomycin—Diarrhoea—Chlorambucil—ovarian cancer	0.000104	0.00121	CcSEcCtD
Dactinomycin—Erythema multiforme—Paclitaxel—ovarian cancer	0.000104	0.0012	CcSEcCtD
Dactinomycin—Stevens-Johnson syndrome—Docetaxel—ovarian cancer	0.000103	0.00119	CcSEcCtD
Dactinomycin—Flushing—Paclitaxel—ovarian cancer	0.000102	0.00118	CcSEcCtD
Dactinomycin—Stomatitis—Docetaxel—ovarian cancer	0.000101	0.00117	CcSEcCtD
Dactinomycin—Hepatic failure—Epirubicin—ovarian cancer	0.000101	0.00117	CcSEcCtD
Dactinomycin—Decreased appetite—Vinorelbine—ovarian cancer	0.000101	0.00117	CcSEcCtD
Dactinomycin—Sepsis—Doxorubicin—ovarian cancer	0.0001	0.00116	CcSEcCtD
Dactinomycin—Fatigue—Vinorelbine—ovarian cancer	0.0001	0.00116	CcSEcCtD
Dactinomycin—Hypersensitivity—Topotecan—ovarian cancer	9.99e-05	0.00116	CcSEcCtD
Dactinomycin—Pain—Vinorelbine—ovarian cancer	9.92e-05	0.00115	CcSEcCtD
Dactinomycin—Chills—Paclitaxel—ovarian cancer	9.85e-05	0.00114	CcSEcCtD
Dactinomycin—Hypersensitivity—Melphalan—ovarian cancer	9.78e-05	0.00113	CcSEcCtD
Dactinomycin—Phlebitis—Doxorubicin—ovarian cancer	9.75e-05	0.00113	CcSEcCtD
Dactinomycin—Asthenia—Topotecan—ovarian cancer	9.73e-05	0.00112	CcSEcCtD
Dactinomycin—Alopecia—Paclitaxel—ovarian cancer	9.7e-05	0.00112	CcSEcCtD
Dactinomycin—Vomiting—Chlorambucil—ovarian cancer	9.68e-05	0.00112	CcSEcCtD
Dactinomycin—Agranulocytosis—Docetaxel—ovarian cancer	9.67e-05	0.00112	CcSEcCtD
Dactinomycin—Erythema—Paclitaxel—ovarian cancer	9.56e-05	0.00111	CcSEcCtD
Dactinomycin—Feeling abnormal—Vinorelbine—ovarian cancer	9.56e-05	0.00111	CcSEcCtD
Dactinomycin—Asthenia—Melphalan—ovarian cancer	9.52e-05	0.0011	CcSEcCtD
Dactinomycin—ABCB1—female reproductive system—ovarian cancer	9.51e-05	0.0125	CbGeAlD
Dactinomycin—Gastrointestinal pain—Vinorelbine—ovarian cancer	9.48e-05	0.0011	CcSEcCtD
Dactinomycin—Hepatic failure—Doxorubicin—ovarian cancer	9.34e-05	0.00108	CcSEcCtD
Dactinomycin—Hepatitis—Docetaxel—ovarian cancer	9.31e-05	0.00108	CcSEcCtD
Dactinomycin—Diarrhoea—Topotecan—ovarian cancer	9.28e-05	0.00107	CcSEcCtD
Dactinomycin—Lethargy—Epirubicin—ovarian cancer	9.26e-05	0.00107	CcSEcCtD
Dactinomycin—Pharyngitis—Docetaxel—ovarian cancer	9.24e-05	0.00107	CcSEcCtD
Dactinomycin—Abdominal pain—Vinorelbine—ovarian cancer	9.17e-05	0.00106	CcSEcCtD
Dactinomycin—Body temperature increased—Vinorelbine—ovarian cancer	9.17e-05	0.00106	CcSEcCtD
Dactinomycin—Diarrhoea—Melphalan—ovarian cancer	9.08e-05	0.00105	CcSEcCtD
Dactinomycin—Nausea—Chlorambucil—ovarian cancer	9.05e-05	0.00105	CcSEcCtD
Dactinomycin—ABCB1—bone marrow—ovarian cancer	8.98e-05	0.0118	CbGeAlD
Dactinomycin—Ill-defined disorder—Paclitaxel—ovarian cancer	8.87e-05	0.00103	CcSEcCtD
Dactinomycin—Anaemia—Paclitaxel—ovarian cancer	8.83e-05	0.00102	CcSEcCtD
Dactinomycin—Erythema multiforme—Docetaxel—ovarian cancer	8.8e-05	0.00102	CcSEcCtD
Dactinomycin—ABCB1—female gonad—ovarian cancer	8.66e-05	0.0114	CbGeAlD
Dactinomycin—Flushing—Docetaxel—ovarian cancer	8.64e-05	0.000999	CcSEcCtD
Dactinomycin—Vomiting—Topotecan—ovarian cancer	8.62e-05	0.000997	CcSEcCtD
Dactinomycin—Malaise—Paclitaxel—ovarian cancer	8.62e-05	0.000997	CcSEcCtD
Dactinomycin—ABCB1—vagina—ovarian cancer	8.6e-05	0.0113	CbGeAlD
Dactinomycin—Lethargy—Doxorubicin—ovarian cancer	8.57e-05	0.000991	CcSEcCtD
Dactinomycin—Leukopenia—Paclitaxel—ovarian cancer	8.56e-05	0.000989	CcSEcCtD
Dactinomycin—Rash—Topotecan—ovarian cancer	8.55e-05	0.000989	CcSEcCtD
Dactinomycin—Hypersensitivity—Vinorelbine—ovarian cancer	8.54e-05	0.000988	CcSEcCtD
Dactinomycin—Vomiting—Melphalan—ovarian cancer	8.44e-05	0.000976	CcSEcCtD
Dactinomycin—Liver function test abnormal—Epirubicin—ovarian cancer	8.38e-05	0.000969	CcSEcCtD
Dactinomycin—Rash—Melphalan—ovarian cancer	8.37e-05	0.000968	CcSEcCtD
Dactinomycin—Chills—Docetaxel—ovarian cancer	8.35e-05	0.000966	CcSEcCtD
Dactinomycin—Asthenia—Vinorelbine—ovarian cancer	8.32e-05	0.000962	CcSEcCtD
Dactinomycin—Alopecia—Docetaxel—ovarian cancer	8.22e-05	0.000951	CcSEcCtD
Dactinomycin—Toxic epidermal necrolysis—Epirubicin—ovarian cancer	8.17e-05	0.000945	CcSEcCtD
Dactinomycin—Aspartate aminotransferase increased—Epirubicin—ovarian cancer	8.17e-05	0.000945	CcSEcCtD
Dactinomycin—Myalgia—Paclitaxel—ovarian cancer	8.14e-05	0.000941	CcSEcCtD
Dactinomycin—Erythema—Docetaxel—ovarian cancer	8.1e-05	0.000937	CcSEcCtD
Dactinomycin—Nausea—Topotecan—ovarian cancer	8.05e-05	0.000931	CcSEcCtD
Dactinomycin—Discomfort—Paclitaxel—ovarian cancer	8.04e-05	0.00093	CcSEcCtD
Dactinomycin—Diarrhoea—Vinorelbine—ovarian cancer	7.94e-05	0.000918	CcSEcCtD
Dactinomycin—Nausea—Melphalan—ovarian cancer	7.89e-05	0.000912	CcSEcCtD
Dactinomycin—Dysphagia—Epirubicin—ovarian cancer	7.84e-05	0.000907	CcSEcCtD
Dactinomycin—Oedema—Paclitaxel—ovarian cancer	7.8e-05	0.000902	CcSEcCtD
Dactinomycin—Liver function test abnormal—Doxorubicin—ovarian cancer	7.75e-05	0.000896	CcSEcCtD
Dactinomycin—Infection—Paclitaxel—ovarian cancer	7.75e-05	0.000896	CcSEcCtD
Dactinomycin—ABCB1—testis—ovarian cancer	7.68e-05	0.0101	CbGeAlD
Dactinomycin—Thrombocytopenia—Paclitaxel—ovarian cancer	7.64e-05	0.000883	CcSEcCtD
Dactinomycin—Aspartate aminotransferase increased—Doxorubicin—ovarian cancer	7.56e-05	0.000874	CcSEcCtD
Dactinomycin—Toxic epidermal necrolysis—Doxorubicin—ovarian cancer	7.56e-05	0.000874	CcSEcCtD
Dactinomycin—Anaemia—Docetaxel—ovarian cancer	7.49e-05	0.000866	CcSEcCtD
Dactinomycin—Pancytopenia—Epirubicin—ovarian cancer	7.45e-05	0.000861	CcSEcCtD
Dactinomycin—Anorexia—Paclitaxel—ovarian cancer	7.44e-05	0.00086	CcSEcCtD
Dactinomycin—Vomiting—Vinorelbine—ovarian cancer	7.37e-05	0.000853	CcSEcCtD
Dactinomycin—Neutropenia—Epirubicin—ovarian cancer	7.33e-05	0.000848	CcSEcCtD
Dactinomycin—Rash—Vinorelbine—ovarian cancer	7.31e-05	0.000846	CcSEcCtD
Dactinomycin—Dysphagia—Doxorubicin—ovarian cancer	7.26e-05	0.000839	CcSEcCtD
Dactinomycin—Leukopenia—Docetaxel—ovarian cancer	7.25e-05	0.000839	CcSEcCtD
Dactinomycin—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	7.11e-05	0.000822	CcSEcCtD
Dactinomycin—Pneumonia—Epirubicin—ovarian cancer	7.03e-05	0.000813	CcSEcCtD
Dactinomycin—Stevens-Johnson syndrome—Epirubicin—ovarian cancer	6.93e-05	0.000802	CcSEcCtD
Dactinomycin—Myalgia—Docetaxel—ovarian cancer	6.9e-05	0.000798	CcSEcCtD
Dactinomycin—Pancytopenia—Doxorubicin—ovarian cancer	6.89e-05	0.000797	CcSEcCtD
Dactinomycin—Nausea—Vinorelbine—ovarian cancer	6.89e-05	0.000797	CcSEcCtD
Dactinomycin—Stomatitis—Epirubicin—ovarian cancer	6.82e-05	0.000788	CcSEcCtD
Dactinomycin—Neutropenia—Doxorubicin—ovarian cancer	6.79e-05	0.000785	CcSEcCtD
Dactinomycin—Decreased appetite—Paclitaxel—ovarian cancer	6.78e-05	0.000784	CcSEcCtD
Dactinomycin—Fatigue—Paclitaxel—ovarian cancer	6.73e-05	0.000778	CcSEcCtD
Dactinomycin—Pain—Paclitaxel—ovarian cancer	6.67e-05	0.000771	CcSEcCtD
Dactinomycin—Oedema—Docetaxel—ovarian cancer	6.61e-05	0.000765	CcSEcCtD
Dactinomycin—Infection—Docetaxel—ovarian cancer	6.57e-05	0.00076	CcSEcCtD
Dactinomycin—Agranulocytosis—Epirubicin—ovarian cancer	6.53e-05	0.000755	CcSEcCtD
Dactinomycin—Pneumonia—Doxorubicin—ovarian cancer	6.51e-05	0.000753	CcSEcCtD
Dactinomycin—Thrombocytopenia—Docetaxel—ovarian cancer	6.47e-05	0.000749	CcSEcCtD
Dactinomycin—Feeling abnormal—Paclitaxel—ovarian cancer	6.43e-05	0.000743	CcSEcCtD
Dactinomycin—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	6.41e-05	0.000742	CcSEcCtD
Dactinomycin—Gastrointestinal pain—Paclitaxel—ovarian cancer	6.38e-05	0.000738	CcSEcCtD
Dactinomycin—Stomatitis—Doxorubicin—ovarian cancer	6.31e-05	0.000729	CcSEcCtD
Dactinomycin—Anorexia—Docetaxel—ovarian cancer	6.3e-05	0.000729	CcSEcCtD
Dactinomycin—Hepatitis—Epirubicin—ovarian cancer	6.28e-05	0.000726	CcSEcCtD
Dactinomycin—Pharyngitis—Epirubicin—ovarian cancer	6.23e-05	0.000721	CcSEcCtD
Dactinomycin—Abdominal pain—Paclitaxel—ovarian cancer	6.17e-05	0.000713	CcSEcCtD
Dactinomycin—Body temperature increased—Paclitaxel—ovarian cancer	6.17e-05	0.000713	CcSEcCtD
Dactinomycin—Agranulocytosis—Doxorubicin—ovarian cancer	6.04e-05	0.000698	CcSEcCtD
Dactinomycin—Musculoskeletal discomfort—Docetaxel—ovarian cancer	6.02e-05	0.000697	CcSEcCtD
Dactinomycin—Erythema multiforme—Epirubicin—ovarian cancer	5.94e-05	0.000686	CcSEcCtD
Dactinomycin—Flushing—Epirubicin—ovarian cancer	5.83e-05	0.000674	CcSEcCtD
Dactinomycin—Hepatitis—Doxorubicin—ovarian cancer	5.81e-05	0.000672	CcSEcCtD
Dactinomycin—Pharyngitis—Doxorubicin—ovarian cancer	5.76e-05	0.000667	CcSEcCtD
Dactinomycin—Decreased appetite—Docetaxel—ovarian cancer	5.75e-05	0.000665	CcSEcCtD
Dactinomycin—Hypersensitivity—Paclitaxel—ovarian cancer	5.75e-05	0.000665	CcSEcCtD
Dactinomycin—Fatigue—Docetaxel—ovarian cancer	5.7e-05	0.000659	CcSEcCtD
Dactinomycin—Pain—Docetaxel—ovarian cancer	5.65e-05	0.000654	CcSEcCtD
Dactinomycin—Chills—Epirubicin—ovarian cancer	5.63e-05	0.000651	CcSEcCtD
Dactinomycin—Asthenia—Paclitaxel—ovarian cancer	5.6e-05	0.000647	CcSEcCtD
Dactinomycin—ABCB1—lymph node—ovarian cancer	5.57e-05	0.0073	CbGeAlD
Dactinomycin—Alopecia—Epirubicin—ovarian cancer	5.55e-05	0.000642	CcSEcCtD
Dactinomycin—Erythema multiforme—Doxorubicin—ovarian cancer	5.49e-05	0.000635	CcSEcCtD
Dactinomycin—Erythema—Epirubicin—ovarian cancer	5.46e-05	0.000632	CcSEcCtD
Dactinomycin—Feeling abnormal—Docetaxel—ovarian cancer	5.45e-05	0.00063	CcSEcCtD
Dactinomycin—Gastrointestinal pain—Docetaxel—ovarian cancer	5.41e-05	0.000625	CcSEcCtD
Dactinomycin—Flushing—Doxorubicin—ovarian cancer	5.39e-05	0.000623	CcSEcCtD
Dactinomycin—Diarrhoea—Paclitaxel—ovarian cancer	5.34e-05	0.000617	CcSEcCtD
Dactinomycin—Abdominal pain—Docetaxel—ovarian cancer	5.23e-05	0.000604	CcSEcCtD
Dactinomycin—Body temperature increased—Docetaxel—ovarian cancer	5.23e-05	0.000604	CcSEcCtD
Dactinomycin—Chills—Doxorubicin—ovarian cancer	5.21e-05	0.000603	CcSEcCtD
Dactinomycin—Alopecia—Doxorubicin—ovarian cancer	5.13e-05	0.000594	CcSEcCtD
Dactinomycin—Ill-defined disorder—Epirubicin—ovarian cancer	5.07e-05	0.000586	CcSEcCtD
Dactinomycin—Erythema—Doxorubicin—ovarian cancer	5.06e-05	0.000585	CcSEcCtD
Dactinomycin—Anaemia—Epirubicin—ovarian cancer	5.05e-05	0.000584	CcSEcCtD
Dactinomycin—Vomiting—Paclitaxel—ovarian cancer	4.96e-05	0.000574	CcSEcCtD
Dactinomycin—Malaise—Epirubicin—ovarian cancer	4.93e-05	0.00057	CcSEcCtD
Dactinomycin—Rash—Paclitaxel—ovarian cancer	4.92e-05	0.000569	CcSEcCtD
Dactinomycin—Leukopenia—Epirubicin—ovarian cancer	4.89e-05	0.000566	CcSEcCtD
Dactinomycin—Hypersensitivity—Docetaxel—ovarian cancer	4.87e-05	0.000563	CcSEcCtD
Dactinomycin—Asthenia—Docetaxel—ovarian cancer	4.74e-05	0.000549	CcSEcCtD
Dactinomycin—Ill-defined disorder—Doxorubicin—ovarian cancer	4.69e-05	0.000543	CcSEcCtD
Dactinomycin—Anaemia—Doxorubicin—ovarian cancer	4.67e-05	0.00054	CcSEcCtD
Dactinomycin—Myalgia—Epirubicin—ovarian cancer	4.65e-05	0.000538	CcSEcCtD
Dactinomycin—Nausea—Paclitaxel—ovarian cancer	4.63e-05	0.000536	CcSEcCtD
Dactinomycin—Discomfort—Epirubicin—ovarian cancer	4.6e-05	0.000532	CcSEcCtD
Dactinomycin—Malaise—Doxorubicin—ovarian cancer	4.56e-05	0.000527	CcSEcCtD
Dactinomycin—Leukopenia—Doxorubicin—ovarian cancer	4.53e-05	0.000523	CcSEcCtD
Dactinomycin—Diarrhoea—Docetaxel—ovarian cancer	4.52e-05	0.000523	CcSEcCtD
Dactinomycin—Oedema—Epirubicin—ovarian cancer	4.46e-05	0.000516	CcSEcCtD
Dactinomycin—Infection—Epirubicin—ovarian cancer	4.43e-05	0.000512	CcSEcCtD
Dactinomycin—Thrombocytopenia—Epirubicin—ovarian cancer	4.37e-05	0.000505	CcSEcCtD
Dactinomycin—Myalgia—Doxorubicin—ovarian cancer	4.3e-05	0.000498	CcSEcCtD
Dactinomycin—Discomfort—Doxorubicin—ovarian cancer	4.25e-05	0.000492	CcSEcCtD
Dactinomycin—Anorexia—Epirubicin—ovarian cancer	4.25e-05	0.000492	CcSEcCtD
Dactinomycin—Vomiting—Docetaxel—ovarian cancer	4.2e-05	0.000486	CcSEcCtD
Dactinomycin—Rash—Docetaxel—ovarian cancer	4.17e-05	0.000482	CcSEcCtD
Dactinomycin—Oedema—Doxorubicin—ovarian cancer	4.13e-05	0.000477	CcSEcCtD
Dactinomycin—Infection—Doxorubicin—ovarian cancer	4.1e-05	0.000474	CcSEcCtD
Dactinomycin—Musculoskeletal discomfort—Epirubicin—ovarian cancer	4.06e-05	0.00047	CcSEcCtD
Dactinomycin—Thrombocytopenia—Doxorubicin—ovarian cancer	4.04e-05	0.000467	CcSEcCtD
Dactinomycin—Anorexia—Doxorubicin—ovarian cancer	3.93e-05	0.000455	CcSEcCtD
Dactinomycin—Nausea—Docetaxel—ovarian cancer	3.93e-05	0.000454	CcSEcCtD
Dactinomycin—Decreased appetite—Epirubicin—ovarian cancer	3.88e-05	0.000448	CcSEcCtD
Dactinomycin—Fatigue—Epirubicin—ovarian cancer	3.85e-05	0.000445	CcSEcCtD
Dactinomycin—Pain—Epirubicin—ovarian cancer	3.81e-05	0.000441	CcSEcCtD
Dactinomycin—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	3.76e-05	0.000435	CcSEcCtD
Dactinomycin—Feeling abnormal—Epirubicin—ovarian cancer	3.68e-05	0.000425	CcSEcCtD
Dactinomycin—Gastrointestinal pain—Epirubicin—ovarian cancer	3.65e-05	0.000422	CcSEcCtD
Dactinomycin—Decreased appetite—Doxorubicin—ovarian cancer	3.59e-05	0.000415	CcSEcCtD
Dactinomycin—Fatigue—Doxorubicin—ovarian cancer	3.56e-05	0.000411	CcSEcCtD
Dactinomycin—Pain—Doxorubicin—ovarian cancer	3.53e-05	0.000408	CcSEcCtD
Dactinomycin—Abdominal pain—Epirubicin—ovarian cancer	3.53e-05	0.000408	CcSEcCtD
Dactinomycin—Body temperature increased—Epirubicin—ovarian cancer	3.53e-05	0.000408	CcSEcCtD
Dactinomycin—Feeling abnormal—Doxorubicin—ovarian cancer	3.4e-05	0.000393	CcSEcCtD
Dactinomycin—Gastrointestinal pain—Doxorubicin—ovarian cancer	3.37e-05	0.00039	CcSEcCtD
Dactinomycin—Hypersensitivity—Epirubicin—ovarian cancer	3.29e-05	0.00038	CcSEcCtD
Dactinomycin—Abdominal pain—Doxorubicin—ovarian cancer	3.26e-05	0.000377	CcSEcCtD
Dactinomycin—Body temperature increased—Doxorubicin—ovarian cancer	3.26e-05	0.000377	CcSEcCtD
Dactinomycin—Asthenia—Epirubicin—ovarian cancer	3.2e-05	0.00037	CcSEcCtD
Dactinomycin—Diarrhoea—Epirubicin—ovarian cancer	3.05e-05	0.000353	CcSEcCtD
Dactinomycin—Hypersensitivity—Doxorubicin—ovarian cancer	3.04e-05	0.000352	CcSEcCtD
Dactinomycin—Asthenia—Doxorubicin—ovarian cancer	2.96e-05	0.000342	CcSEcCtD
Dactinomycin—Vomiting—Epirubicin—ovarian cancer	2.84e-05	0.000328	CcSEcCtD
Dactinomycin—Diarrhoea—Doxorubicin—ovarian cancer	2.82e-05	0.000327	CcSEcCtD
Dactinomycin—Rash—Epirubicin—ovarian cancer	2.81e-05	0.000325	CcSEcCtD
Dactinomycin—Nausea—Epirubicin—ovarian cancer	2.65e-05	0.000306	CcSEcCtD
Dactinomycin—Vomiting—Doxorubicin—ovarian cancer	2.62e-05	0.000303	CcSEcCtD
Dactinomycin—Rash—Doxorubicin—ovarian cancer	2.6e-05	0.000301	CcSEcCtD
Dactinomycin—Nausea—Doxorubicin—ovarian cancer	2.45e-05	0.000283	CcSEcCtD
